Target intelligence / Profile preview

Protein PAT1 homolog 1 (PATL1)

Target
PATL1
Molecular classification
Other (RNA-binding protein, mRNA decay factor; not a classical receptor, enzyme, transporter, or channel)
01

Overview

Protein PAT1 homolog 1 (PATL1) is an evolutionarily conserved RNA-binding protein that acts as a scaffold supporting the assembly and function of the deadenylation-dependent decapping machinery, central to cytoplasmic mRNA decay. As a core component of processing bodies (P-bodies), PATL1 controls gene expression at the post-transcriptional level by directing selective mRNA translational repression and promoting mRNA degradation. PATL1 exhibits poly(G) and poly(U) RNA binding, enabling its function in coordinating the activities of deadenylases, decapping enzymes (e.g., DCP1/DCP2), and other decay factors like the Lsm1-7 complex. In addition to its cytoplasmic roles, PATL1 is present in the nucleus, where it can affect transcriptional events and contribute to specialized pathways such as hERG K(+) channel biogenesis by regulating mRNA output of the KCNH2 gene. In some contexts, such as viral infection, PATL1 is indispensable for virus (e.g., HCV) replication due to its role in viral mRNA translation and stability. Despite these many roles, PATL1 is not established as a classical therapeutic target such as a receptor or enzyme; it is mainly a regulator of post-transcriptional gene expression.

Other names
Pat1bhPat1bOK/KNS-cl.5FLJ36874PAT1-like protein 1protein associated with topoisomerase II homolog 1
02

Mechanism of action

Not applicable; no approved drugs target PATL1. It functions in mRNA decay and translation regulation rather than as a conventional drug target

03

Biological functions

Deadenylation-dependent decapping of mRNAmRNA decay and turnoverScaffold for deadenylation and decapping machinerymRNA translation repressionAssembly of cytoplasmic processing bodies (P-bodies)Regulation of gene expression at the post-transcriptional levelFacilitates biogenesis and transcriptional regulation of certain channels, e.g., hERG K(+) channel
04

Disease associations

Associated (by genetic, not necessarily causal, links) with Hermansky-Pudlak Syndrome 7 and Retinitis Pigmentosa 13Shown to be required for hepatitis C virus (HCV) replication during infection

Beyond the preview

Go deeper on Protein PAT1 homolog 1 (PATL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein PAT1 homolog 1 (PATL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call